Cellularis Biomodels Lda

Cellularis Biomodels Lda is an SME in Ilhavo, Portugal that has taken part in 6 EU-funded projects since 2022, receiving €2.8M in EU funding.

EU funding received€2.8M
EU projects6
As coordinator0
Running now5
First EU project2022
Latest project2027
CountryPortugal
EU registration (PIC)888857561
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Cellularis Biomodels Lda's own share of each project, not the project's full budget.

  • Horizon Europe€2.8M · 6 projects

Projects

6 EU-funded projects, newest first. Each links to the official record.

  • VirIONPartner

    Inter-organelle crosstalk in viral infections: identifying peroxisome-related targets for novel broad-spectrum antiviral strategies

    Horizon Europe · 2027–2030 · Project on CORDIS ↗

    €279ktheir share
  • NanoBiCarPartner

    NanoBiCar: A novel immunotherapy for infectious diseases

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

    €538ktheir share
  • OMICSENSPartner

    integrated nano-photonic OMICs bio-SENSor for lung cancer

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

    €539ktheir share
  • NatProLubPartner

    NATURE-INSPIRED PROPHYLACTIC LUBRICANTS AGAINST HIV-1 AND HSV-2

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €540ktheir share
  • EdiGenTPartner

    New Prime Editing and non-viral delivery strategies for Gene Therapy

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €449ktheir share
  • INSPIREPartner

    Developing novel inhaled bioengineered Extracellular Vesicle RNA based advanced therapeutics, delivered by tailored aerosol delivery technology for the treatment of lung cancer

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €446ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA viruses
  • HIV
  • RNA
  • antibiotic resistance
  • antibiotics
  • antivirals
  • artificial intelligence
  • biosensors
  • cell biology
  • gene therapy
  • immunology
  • immunotherapy
  • infectious diseases
  • lubrication

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime